Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-12-22

Clinical Trial Update: Xylitol for Otitis Media [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial of Xylitol for Otitis Media in Phase 2/3 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xylitol (xylitol)

Snippet

Sponsor: Duke University | Conditions: Otitis Media With Effusion | Phase 2, Phase 3 | Status: WITHDRAWN